2009 Vienna - European Society of Human Genetics

Keyword Index
mitochondriopathy: P13.34
mitosis: PL2.5
MLD: P02.072
MLH1: P03.049, P06.032, P06.079
MLL amplification: P06.194
MLL-AF1q: P06.195
MLPA: P02.074, P02.075, P02.179,
P03.029, P03.168, P05.35, P06.130,
P06.190, P11.077, P12.003, P12.079,
P12.086, P12.133, P12.137, P12.151,
P12.165, P15.08, P16.26, P16.41, P17.67
MLPA`: P02.171
MMAB and MMACHC: P13.05
MME: P09.036
MMP1: P17.17
MMP-9: P08.43
MMR genes: P06.148, P06.151
Mn-SOD: P10.13
modifier gene: P10.55, P12.058
MODY: P17.09, S04.2
Moldavian population: P08.45
molecular analysis: P12.074
Molecular biology-skin biology: P12.056
Molecular Combing: P11.037
molecular cytogenetics: P01.49
Molecular Diagnosis: P02.128
molecular diagnostics: P02.182, P12.135,
P16.49
molecular genetics: P12.059, P12.114
molecular karyotype: P03.074
molecular karyotyping: P02.192, P03.070,
S09.1
molecular mechanisms: P06.068, P12.115
Molecular pathologies: P06.203
Molecular: P01.36
monilethrix: P02.052
monitoring: P06.192
Monocyte: P09.121
monogenic diabetes: P17.09, S04.2
monogenic diseases: P04.23, P05.28
Monogenic disorders: P05.22
monogenic hereditary ophthalmopathology:
P10.56
monosomy 18p: P03.130
Monosomy 2q: P06.182
Morbidity: P04.06
Morocco: P10.09
morphine sensitization: P02.076
mosaicism: P03.099, P04.21, P05.38,
P06.160, P09.020, P12.031
Motivation: P01.26
mouse models: P11.078
MPO gene: P08.44, P10.57
MPS: P05.26, P13.40
MPS1: P13.35
MR/MCA: P11.006
Mre11: P06.040
MRKH syndrome: P03.100
mRNA expression: P10.42
mRNA splicing: S02.3
mRNA stability: P06.095
mRNA: P02.122
MRP1: P06.178
MS: P12.154
MSH2: P06.145, P06.147
MSH6: P06.146, P06.152
MSI: P06.150
MS-MLPA: P06.084
MSX1: P02.020
mt DNA mutations: P16.15
MT-ATP8: P12.113
mtDNA control region: P10.59
mtDNA deletions: P06.022
mtDNA depletion: P13.36, P13.44, P13.45
mtDNA genome diversity: P10.60
mtDNA mutations: P11.075, P12.066
mtDNA: P06.013, P09.074, P10.58,
P11.079, P13.30, P13.34, P16.22,
P17.50, S12.1
MTHFR C677T: P09.075, P09.076, P17.19
MTHFR polymorphism: P09.086
MTHFR: P03.195, P04.12, P08.45,
P09.087, P17.34, P17.36
mTOR: S04.1
mucolipidosis type II: P13.37
Mucopolisaccharidosis: P13.38
mucopolysaccharidoses: P13.39
mucopolysaccharidosis IIIC: P13.41
Mucopolysaccharidosis VI: P14.13
Mucopolysaccharidosis: P02.077, P05.26,
P13.40
Müllerian aplasia: P03.196
multidisciplinary: P02.042
multidrug resistance: P10.52
multifactorial diseases: P01.28
multiple congenital anomalies: P02.078
Multiple endocrine neoplasia type 2:
P06.061
multiple mutations: C15.3
multiple myeloma: P06.193, P06.196,
P06.197
MULTIPLE SCLEROSIS: P02.064,
P09.009, P09.042, P09.077, P09.078,
P09.079, P09.080, P09.081, P15.01
Multiple self-healing squamous epithelioma:
P08.46
Multiple Sklerosis: P09.082
multiplex family: P02.087
multiplex PCR: P11.001
Multiplex: P11.112
multiplexed sequencing: P11.024
Multiply congenital development defects:
P10.61
Multipoint linkage approach: P08.02
MURCS: P02.079
Muscle disease: P16.48
muscle hypertrophy: P03.063
muscle mass: P09.022
Muscular dystrophy: P16.49
musical aptitude: P09.083
Mustard gas: P03.043
mutation analysis: C11.6, P02.146,
P12.079, P16.25
mutation database: P06.090, P11.011
mutation databases: P11.080
MUTATION DETECTION: P02.117,
P02.132, P06.017, P16.27, PL2.2
Mutation load: P16.03
mutation pattern: P12.130
mutation testing: P06.062
mutation: C13.3, P02.046, P02.128,
P02.133, P06.127, P08.05, P09.064,
P09.123, P11.080, P11.110, P12.015,
P12.037, P12.041, P12.042, P12.062,
P12.080, P12.111, P12.120, P12.142,
P16.35, P16.42, P17.10
mutational spectrum: C18.4
Mutations: C01.6, C04.5, P12.004,
P12.005, P12.116, P12.167, P13.11,
P16.43, P16.46, P17.46, P17.53
muts: P06.062
MUTYH: C01.5, P06.153, P06.163
Myasthenia Gravis: P09.084
MyBPC3: P16.13, P16.24
MYH11: P12.109
MYH7: P16.11
Myhre syndrome: P02.080
MYO15A: P02.043
MYOC: P12.070
Myocardial infarction: P10.22, P17.17,
P17.35
myoma: P04.13
myopathy: P13.48
Myotonia congenita: P16.50
myotonic dystrophy type 1: P10.62, P16.53
Myotonic Dystrophy: P11.081, P16.51,
P16.52, S07.3
MZ twins: P13.35
N
N-acetylation: P09.097
NADH dehydrogenase genes: P12.066
NAIP: P06.106
NALP2: C08.6
Nance-Horan syndrome: P12.117
nanobioparticle: P14.14
NARP: C07.4
nasal polyposis: P09.085